Nucleic acid amplification with exponential cardinality greater than cardinality 2 using high and low Tm primers

By using high and low Tm primers combinations of different melting temperatures and introducing high Tm primer temperature pulses during PCR, the problem of insufficient amplification efficiency and sensitivity in existing PCR technologies is solved, achieving faster and more efficient DNA amplification.

CN118974277APending Publication Date: 2024-11-15赛沛公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380030254.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-02-15
Filing Date
2023-02-14
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing PCR technology has limitations in amplification efficiency and sensitivity, making it difficult to detect target DNA present in only a few molecules in a single reaction, and the amplification rate is slow.

Method used

Using a combination of high Tm and low Tm primers with different melting temperatures, the high Tm primer annealing and extension is allowed to be achieved by introducing high Tm primer temperature pulses during the amplification temperature/time process, while the low Tm primer does not anneale and extend. Amplification with cardinality greater than 2.

Benefits of technology

It significantly improves the amplification efficiency and sensitivity of PCR, reduces the number of amplification cycles required to detect target DNA, and improves the detection speed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118974277A_ABST
    Figure CN118974277A_ABST
Patent Text Reader

Abstract

Described herein are methods and compositions that provide efficient nucleic acid amplification. The present invention relates to a method for the synthesis of nucleic acid chains, which employs primer pairs with significantly different Tm, as well as a novel temperature / time process, characterized in that there is a temperature pulse during the denaturation process, such that high Tm primers, rather than low Tm primers, are able to anneal and induce the synthesis of additional nucleic acid chains other than the two chains synthesized in the cycle of classical PCR. In some embodiments, this allows the amplification product per amplification cycle to be increased by 3 times or more, thus having higher sensitivity and speed than conventional PCR.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of U.S. Provisional Application No. 63 / 310,467, filed on February 15, 2022, which is incorporated herein by reference in its entirety.

[0003] STATEMENT REGARDING RIGHTS TO INVENTS RESULTING FROM FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

[0004] not applicable. Technical Field

[0005] The methods and compositions described herein generally relate to the field of nucleic acid amplification. In particular, methods and compositions for improving amplification efficiency are described herein. Background Art

[0006] There are currently a variety of nucleic acid amplification methods to choose from, and many methods have been applied to sensitive diagnostic assays based on nucleic acid detection. Polymerase chain reaction (PCR) remains the most widely used DNA amplification and quantification method. Nested PCR, i.e., two-stage PCR, is used to improve the specificity and sensitivity of PCR (U.S. Patent No. 4,683,195). The nested primers used for PCR amplification are oligonucleotides with sequences complementary to the region between the reverse primer and the forward primer targeting site on the target sequence. However, PCR generally has several limitations. PCR amplification can only achieve an increase of less than two times the number of target sequences per cycle. It is still relatively slow. In addition, the sensitivity of this method is generally limited, making it difficult to detect targets that may only exist in a few molecules in a single reaction.

[0007] Efforts to improve the sensitivity and efficiency of amplification without sacrificing specificity include the use of unique primer sets to achieve amplification greater than base 2 (U.S. Patent No. 10,273,534) and the incorporation of modified bases in primers that preferentially pair with their unmodified complementary bases (U.S. Patent Publication No. 2020 / 0239878).

[0008] Nucleic acid amplification generally includes multiple cycles of the following sequential procedures: annealing of at least two primers to complementary or substantially complementary sequences in a target nucleic acid; synthesis of at least one nucleotide chain using a polymerase in a template-dependent manner; and separation of the chains of the newly formed nucleic acid duplexes to generate templates for subsequent cycles of chain synthesis. In standard PCR, each cycle generates a new nucleic acid duplex from a single target nucleic acid duplex, yielding two nucleic acid duplexes, and thus standard PCR is understood as "base 2" PCR. Base 3 (i.e., three duplexes per cycle) and base 6 (i.e., six duplexes per cycle) can be achieved through unique primer design.

[0009] Amplification can include thermal cycling or can be performed under isothermal conditions. Isothermal amplification generally requires the use of a nucleic acid polymerase with strand displacement activity and / or other methods for achieving strand separation. The standard implementation of thermal cycling is to subject the PCR reaction mixture to three temperatures in each cycle in the following order: denaturation, typically at about 95°C; annealing, typically at a temperature about 5°C below the Tm of the primers; and extension (e.g., at about 72°C). Some methods simplify this temperature / time process to two temperatures per cycle. For example, U.S. Pat. No. 9,428,781 describes "oscillating amplification" in which two temperature cycles include an upper temperature and a lower temperature that differ by no more than 20°C. Regardless of the temperature / time process, the primers are designed to have similar melting temperatures (Tm) so that the two primers anneal under the same reaction conditions. Summary of the invention

[0010] Described herein are methods and compositions using a simple set of two amplification primers for each target nucleic acid, which are clearly designed to have sufficiently different melting temperatures (Tm) so that they anneal under different reaction conditions. They are used for amplification methods that require more complex temperature / time processes per cycle compared to standard PCR. This simple, sophisticated method can be used to achieve an amplification greater than base 2 for any target nucleic acid. Using a primer pair comprising a high Tm primer and a low Tm primer, a single high Tm primer temperature pulse can be introduced in the denaturation phase of the amplification temperature / time process to allow the high Tm primer to anneal and extend, while the low Tm primer does not anneal and extend, thereby achieving a base 3 amplification. Introducing such a temperature pulse in the denaturation phase of the amplification temperature / time process further increases the base of exponential amplification. Therefore, for example, two high Tm primer temperature pulses can produce a base 4 amplification.

[0011] Various embodiments contemplated herein may include, but are not necessarily limited to, one or more of the following:

[0012] Embodiment 1: A method for amplifying a target nucleic acid in a sample to produce a target amplicon, the method comprising using a nucleic acid primer set comprising a high Tm primer and a low Tm primer, wherein: the target nucleic acid comprises a first template strand and an optional second template strand, wherein the second template strand is complementary to the first template strand; the high Tm primer is capable of annealing to the first template strand and initiating an extension product from the high Tm primer; the low Tm primer is capable of annealing to the first extension product and initiating an extension product from the low Tm primer; wherein the Tm of the high Tm primer is at least 5°C higher than the Tm of the low Tm primer.

[0013] Embodiment 2: The method according to embodiment 1, wherein the Tm of the high Tm primer is at least 10°C higher than the Tm of the low Tm primer.

[0014] Embodiment 3: The method according to embodiment 1, wherein the Tm of the high Tm primer is at least 15°C higher than the Tm of the low Tm primer.

[0015] Embodiment 4: The method of Embodiment 1, wherein the Tm of the high Tm primer is at least 20°C higher than the Tm of the low Tm primer.

[0016] Embodiment 5: The method of Embodiment 1, wherein the Tm of the high Tm primer is at least 25°C higher than the Tm of the low Tm primer.

[0017] Embodiment 6: A method according to any of the preceding embodiments, wherein the method comprises: contacting the sample with a reaction mixture comprising the nucleic acid primer set; raising the reaction temperature to a denaturation temperature, thereby denaturing the nucleic acids in the sample; pulsing the reaction by lowering the reaction temperature to a high annealing and extension temperature suitable for producing an extension product from the high Tm primer, and then raising the reaction temperature to the denaturation temperature; lowering the reaction temperature to a low annealing and extension temperature suitable for producing an extension product from the low Tm primer, wherein the high Tm primer also anneals and produces another extension product; wherein the pulse is capable of producing additional amplicons, the number of which exceeds the number of amplicons produced by a single amplification cycle performed on a double-stranded template in the absence of the pulse.

[0018] Embodiment 7: A method according to embodiment 6, wherein the pulse is performed at least once in each amplification cycle.

[0019] Embodiment 8: A method according to embodiment 6, wherein the pulse is performed at least twice in each amplification cycle.

[0020] Embodiment 9: A method according to embodiment 6, wherein the pulse is performed at least three times in each amplification cycle.

[0021] Embodiment 10: A method according to embodiment 6, wherein the pulse is performed at least four times in each amplification cycle.

[0022] Embodiment 11: The method according to any one of Embodiments 6 to 10, wherein:

[0023] The denaturation temperature includes a temperature of 90°C to 100°C;

[0024] The high annealing and extension temperatures include temperatures from 75°C to 85°C; and

[0025] The low annealing and extension temperatures include temperatures from 60°C to 70°C.

[0026] Embodiment 12: A method according to embodiment 11, wherein the method includes performing multiple amplification cycles, wherein each amplification cycle includes subjecting the reaction mixture to the following temperatures in sequence: a denaturation temperature of 92°C to 98°C; a high annealing and extension temperature of 75°C to 83°C; a denaturation temperature of 92°C to 98°C; and a low annealing and extension temperature of 60°C to 66°C.

[0027] Embodiment 13: A method according to any one of Embodiments 6 to 12, wherein the reaction mixture is maintained at the denaturation temperature and the high annealing and extension temperature for the same amount of time, and is maintained at the low annealing and extension temperature for a time longer than that amount of time.

[0028] Embodiment 14: A method according to embodiment 13, wherein each amplification cycle includes, in the following order: denaturation at 94-96°C for 3-6 seconds; high annealing and extension at 79-81°C for 0.1-6 seconds; denaturation at 94-96°C for 3-6 seconds; and low annealing and extension at 63-64°C for 3-8 seconds.

[0029] Embodiment 15: A method according to any of the preceding embodiments, wherein the target nucleic acid is amplified at a rate of at least 3 循环数 rate of expansion.

[0030] Embodiment 16: A method according to embodiment 11, wherein the pulse is performed at least twice in each amplification cycle, and the method includes performing multiple amplification cycles, wherein each amplification cycle includes subjecting the reaction mixture to the following temperatures in sequence: a denaturation temperature of 92°C to 98°C; a high annealing and extension temperature of 75°C to 83°C; a denaturation temperature of 92°C to 98°C; a high annealing and extension temperature of 75°C to 83°C; a denaturation temperature of 92°C to 98°C; and a low annealing and extension temperature including a temperature of 60°C to 66°C.

[0031] Embodiment 17: A method according to Embodiment 16, wherein the reaction mixture is maintained at the denaturation temperature and the high annealing and extension temperature for the same amount of time, and is maintained at the low annealing and extension temperature for twice that amount of time.

[0032] Embodiment 18: A method according to embodiment 17, wherein each amplification cycle includes, in the following order: denaturation at 94-96°C for 3-6 seconds; high annealing and extension at 79-81°C for 0.1-6 seconds; denaturation at 94-96°C for 3-6 seconds; high annealing and extension at 79-81°C for 0.1-6 seconds; denaturation at 94-96°C for 3-6 seconds; and low annealing and extension at 63-64°C for 3-8 seconds.

[0033] Embodiment 19: The method according to any of the preceding embodiments, wherein the method further comprises detecting the target amplicon using a detection probe.

[0034] Embodiment 20: A method according to Embodiment 19, wherein the Tm of the detection probe is between the Tm of the high Tm primer and the Tm of the low Tm primer.

[0035] Embodiment 21: A method according to any of the preceding embodiments, wherein the nucleic acid amplification is a multiplex amplification performed using at least two nucleic acid primer sets for amplifying at least two target nucleic acids, each nucleic acid primer set comprising a high Tm primer and a low Tm primer, wherein, for each nucleic acid primer set, the Tm of the high Tm primer is at least 5°C higher than the Tm of the low Tm primer.

[0036] Embodiment 22: A nucleic acid primer set comprising the primers described in any one of Embodiments 1-4 or 21.

[0037] Embodiment 23: The method of any one of Embodiments 1 to 21 or the nucleic acid primer set of Embodiment 22, wherein the high Tm primer is longer than the low Tm primer.

[0038] Embodiment 24: The method according to any one of Embodiments 1 to 21 or the nucleic acid primer set according to Embodiment 22, wherein the high Tm primer is more GC-rich, or contains more stable bases, than the low Tm primer.

[0039] Embodiment 25: The method according to any one of embodiments 1 to 21 or the nucleic acid primer set according to embodiment 22, wherein the low Tm primer has a lower GC content than the high Tm primer, or contains more destabilizing bases. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 : Schematic diagram showing an illustrative amplicon (target nucleic acid being amplified), a probe for detecting the amplicon, and the relative melting temperatures (Tm) of primers for a standard base 2 PCR ("PCR^2"). As shown, the Tm of the primers differ by a few degrees from each other.

[0041] Figure 2 : Schematic diagram showing an illustrative embodiment of the primers and methods described herein. The method uses primers with significant Tm differences; as shown in the figure, the Tm difference between the high Tm primer and the low Tm primer is at least 10°C.

[0042] Figure 3: Schematic diagram shows an illustrative temperature / time course of a single cycle of an embodiment of the method described herein. The figure shows a single temperature pulse inserted in the 95°C denaturation stage. Prior to this pulse, denaturation has separated the two chains of the target nucleic acid duplex, as shown in the figure. During the temperature pulse, the temperature is reduced to a temperature suitable for the high Tm primer to bind and produce a new nucleic acid chain. In this example, the high Tm primer is a "forward" primer ("F primer"), which produces a "sense" (or "up" or 5' to 3', read from left to right) chain, but the method is also applicable to the high Tm primer is a "reverse" primer ("R primer"), in which case, this step will produce an "antisense" (or "down" or 3' to 5' read from left to right) chain. In either case, the pulse ends with returning to the denaturation temperature and having three nucleic acid chains, each of which can be used as a template when the temperature is reduced to an appropriate temperature, which is suitable for the low Tm primer to bind to the available template (here, two sense chains) and produce new nucleic acid chains. At this temperature, the high Tm primer will also bind to the available template (here, the antisense strand) to generate a new nucleic acid strand. As a result, a single amplification cycle ends with 3 copies of the initial single nucleic acid duplex, thereby achieving base 3 PCR ("PCR^3").

[0043] Figure 4 : Schematic diagram showing an illustrative temperature / time course of a single cycle of one embodiment of the method described herein. The figure shows a single temperature pulse inserted during the denaturation phase at 95°C, with Figure 3 However, Figure 3 The pulses shown are held at a temperature suitable for high Tm primer binding for different periods of time. Figure 4 A pulse in is a rapid spike down of temperature where the temperature is not maintained at a temperature suitable for high Tm primer binding but is raised immediately.

[0044] Figure 5 : PCR results of Example 1: Comparison of real-time amplification curves of hgDNA β-globin housekeeping gene sequences generated by PCR^2 and PCR^3 using TaqMan probes. The left series of curves are from PCR^3 reactions, and the right series of curves are from PCR^2 reactions, showing that PCR^3 has a 10-cycle reduction in Ct values ​​compared to PCR^2.

[0045] Figure 6: PCR results of Example 2: Comparison of PCR^2 with PCR^3 and PCR^4. The exponential portion of the curve from left to right is: PCR^4, PCR^3 and PCR^2. The results reproduced that PCR^3 reduced the Ct value by 10 cycles compared to PCR^2, and showed that PCR^4 also reduced the Ct value by 4 cycles compared to PCR^3.

[0046] Figure 7 Example 3: Comparison of real-time amplification curves of alternative hgDNA β-globin housekeeping gene sequences performed by PCR^2 and PCR^3 using TaqMan probes in a reaction mixture containing 5% (vol / vol) DMSO.

[0047] Figures 8A-8B : Schematic diagram of the design of a convection-driven thermal cycler for PCR (8A) and an illustrative embodiment of the method described herein (8B). DETAILED DESCRIPTION

[0048] definition

[0049] Unless otherwise stated, the terms used in the claims and specification are defined as follows.

[0050] The term "nucleic acid" refers to a polymer of nucleotides and, unless otherwise limited, includes analogs of natural nucleotides that function in a manner similar to (eg, hybridize) naturally occurring nucleotides.

[0051] The term nucleic acid includes any form of DNA or RNA, including, for example, genomic DNA; complementary DNA (cDNA), which is a DNA representation of mRNA, typically obtained by reverse transcription of messenger RNA (mRNA) or amplification; DNA molecules produced by synthesis or amplification; mRNA; and noncoding RNA.

[0052] The term nucleic acid includes double-stranded or triple-stranded nucleic acid complexes, as well as single-stranded molecules. In a double-stranded or triple-stranded nucleic acid complex, the nucleic acid strands are not necessarily coextensive (ie, a double-stranded nucleic acid is not necessarily double-stranded over the entire length of both strands).

[0053] The term nucleic acid also includes any modification thereof, for example by methylation and / or capping. Nucleic acid modifications may include the addition of chemical groups that introduce additional charge, polarizability, hydrogen bonding, electrostatic interactions, and functionality to individual nucleic acid bases or the entire nucleic acid. These modifications may include base modifications such as 2' sugar modifications, 5-pyrimidine modifications, 8-purine modifications, cytosine exocyclic amine modifications, 5-bromo-uracil substitutions, sugar-phosphate backbone modifications, rare base pairing combinations (such as the isobases isocytosine and isoguanine), etc.

[0054] More specifically, in some embodiments, nucleic acids can include polydeoxyribonucleotides (containing 2-deoxy-D-ribose), polyribonucleotides (containing D-ribose), and any other type of nucleic acid that is an N- or C-glycoside of a purine or pyrimidine base, as well as other polymers containing non-nucleotide backbones, such as polyamides (e.g., peptide nucleic acids (PNA)) and polymorpholino polymers (see, e.g., Summerton and Weller (1997) "Morpholino Antisense Oligomers: Design, Preparation, and Properties," Antisense & Nucleic Acid Drug Dev. 7: 1817-195; Okamoto et al. (2002) "Development of electrochemically gene-analyzing method using DNA-modified electrodes," Nucleic Acids Res. Supplement No. 2: 171-172), and other synthetic sequence-specific nucleic acid polymers, provided that the polymer contains nucleoside bases in a configuration that allows base pairing and base stacking, such as found in DNA and RNA. The term "nucleic acid" also includes locked nucleic acids (LNA), which are described in U.S. Patent Nos. 6,794,499, 6,670,461, 6,262,490 and 6,770,748, the entire contents of which are incorporated herein by reference.

[0055] Nucleic acids can be derived from completely chemical synthetic processes (such as solid phase-mediated chemical synthesis), from biological sources (such as by isolation from any species that produces nucleic acids), or from processes involving the manipulation of nucleic acids using molecular biology tools (such as DNA replication, PCR amplification, reverse transcription), or from a combination of these processes.

[0056] As used herein, the term "complementarity" refers to the ability of two nucleotides to pair precisely; that is, if a nucleotide at a given position in a nucleic acid is able to form a canonical base pair with a nucleotide in another nucleic acid through hydrogen bonding, then the two nucleic acids are considered to be complementary to each other at that position. The complementarity between two single-stranded nucleic acid molecules may be "partial", i.e., only some of the nucleotides bind, or it may be complete, i.e., there is complete complementarity between the single-stranded molecules. The degree of complementarity between nucleic acid strands has a significant effect on the efficiency and strength of hybridization between nucleic acid strands.

[0057] "Specific hybridization" refers to the binding of a nucleic acid to a target nucleotide sequence without substantial binding to other nucleotide sequences present in the hybridization mixture under defined stringency conditions. Those skilled in the art recognize that relaxing the stringency of hybridization conditions can tolerate sequence mismatches.

[0058] In some embodiments, hybridization is carried out under stringent hybridization conditions. The phrase "stringent hybridization conditions" generally refers to a temperature that is about 5°C lower than the melting temperature (Tm) of a specific sequence to about 20°C or 25°C under a limited ionic strength and pH value. As used herein, Tm is the temperature at which a double-stranded nucleic acid molecule population is half dissociated into a single strand. The method for calculating nucleic acid Tm is well known in the art (see, e.g., Berger and Kimmel (1987) METHODS IN ENZYMOLOGY, VOL. 152: GUIDE TO MOLECULAR CLONING TECHNIQUES, San Diego: Academic Press, Inc., and Sambrook et al. (1989) MOLECULAR CLONING: A LABORATORY MANUAL, 2nd edition, VOLS. 1-3, Cold Spring Harbor Laboratory), the description of which is incorporated herein by reference to stringent hybridization conditions). As shown in standard references, a simple estimate of Tm values ​​can be calculated by the following equation: T m=81.5+0.41 (%G+C) when the nucleic acid is in 1 M NaCl in aqueous solution (see, e.g., Anderson and Young, Quantitative Filter Hybridization in NUCLEIC ACID HYBRIDIZATION (1985)). The melting temperature of the hybrid (and therefore the conditions of stringent hybridization) is affected by various factors, such as the length and nature of the primer or probe (DNA, RNA, base composition) and the nature of the target nucleic acid (DNA, RNA, base composition, present in solution or immobilized, etc.), as well as the concentration of salts and other components (e.g., the presence or absence of formamide, dextran sulfate, polyethylene glycol). The effects of these factors are well known in the art and are discussed in standard reference texts. Illustrative stringent conditions suitable for achieving most sequence-specific hybridizations are: a temperature of at least about 60°C and a salt concentration of about 0.2 molar at pH 7. Tm calculations for oligonucleotide sequences based on nearest-neighbor thermodynamics can be performed as described in "A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics" John SantaLucia, Jr., PNAS February 17, 1998 vol. 95 no. 4 1460-1465 (the description of which is incorporated herein by reference).

[0059] The term "oligonucleotide" is used to refer to a relatively short nucleic acid, typically shorter than 200 nucleotides, more particularly shorter than 100 nucleotides, and most particularly shorter than 50 nucleotides. Typically, an oligonucleotide is a single-stranded DNA molecule.

[0060] The term "primer" refers to an oligonucleotide that can hybridize (also referred to as "annealing") with nucleic acids and serve as a starting point for nucleotide (RNA or DNA) polymerization under appropriate conditions (i.e., in the presence of four different nucleoside triphosphates and a polymerization reagent (such as DNA or RNA polymerase or reverse transcriptase)) in an appropriate buffer and a suitable temperature. The appropriate length of the primer depends on the intended use of the primer, but the primer is generally at least 7 nucleotides long, in certain embodiments, 10 to 30 nucleotides in length, or in certain embodiments, 10 to 60 nucleotides in length. In certain embodiments, the primer can be, for example, 15 to 50 nucleotides long. Short primer molecules generally require lower temperatures to form sufficiently stable hybrid complexes with the template. The primer does not have to reflect the exact sequence of the template, but must be sufficiently complementary to hybridize with the template.

[0061] If the primer or a portion thereof hybridizes to a nucleotide sequence within another nucleic acid, the primer is said to anneal to the nucleic acid. The statement that a primer hybridizes to a specific nucleotide sequence is not intended to imply that the primer hybridizes completely or exclusively to that nucleotide sequence. For example, in certain embodiments, the amplification primers used herein are referred to as "annealing to" or "specific for" a nucleotide sequence. This description includes primers that completely anneal to a nucleotide sequence, as well as primers that partially anneal to a nucleotide sequence.

[0062] The term "primer pair" refers to a set of primers, including: a 5' "upstream primer" or "forward primer" that hybridizes with the complementary portion of the 5' end of the DNA sequence to be amplified, and a 3' "downstream primer" or "reverse primer" that hybridizes with the 3' end of the sequence to be amplified. As known to those skilled in the art, the terms "upstream" and "downstream" or "forward" and "reverse" are not intended to be limiting, but provide illustrative directions in certain embodiments.

[0063] "Probe" is a nucleic acid that can bind to a target nucleic acid of a complementary sequence through one or more types of chemical bonds, usually through complementary base pairing, generally through hydrogen bond formation, to form a duplex structure. The probe can be labeled with a detectable marker so that the probe is easily detected, particularly after the probe hybridizes with its complementary target. However, alternatively, the probe can also be unlabeled, but can be detected by specific binding to a labeled ligand (whether directly or indirectly labeled). The size of the probe can vary greatly. Usually, the probe is at least 7 to 15 nucleotides long. Other probes are at least 20, 30 or 40 nucleotides long. There are other probes that are slightly longer, at least 50, 60, 70, 80 or 90 nucleotides long. Other probes are even longer, at least 100, 150, 200 or more nucleotides long. The probe can also be any length (e.g., 15 to 20 nucleotides in length) within any range defined by any of the above values.

[0064] Primers or probes may be completely complementary to the target nucleotide sequence, or may not be completely complementary. In certain embodiments, the primer has at least 65% identity with the complementary portion of the target nucleotide sequence over a sequence of at least 7 nucleotides, more typically over a sequence of 10 to 30 nucleotides, and in certain embodiments, over a sequence of at least 14 to 25 nucleotides; and in certain embodiments, at least 75% identity, at least 85% identity, at least 90% identity, or at least 95%, 96%, 97%, 98% or 99% identity. It is understood that certain bases (e.g., the 3' end base of the primer) are generally required to be completely complementary to the corresponding bases in the target nucleotide sequence. Primers and probes are generally annealed to the target sequence under stringent hybridization conditions.

[0065] As used herein, the term "specific for" a nucleic acid with respect to a portion of a primer or a nucleotide sequence in a primer refers to a primer or a nucleotide sequence that can specifically anneal to a target nucleic acid under appropriate annealing conditions.

[0066] Amplification according to the teachings of the present invention includes any means of replicating at least a portion of at least one target nucleic acid, typically in a template-dependent manner, including, but not limited to, a wide range of techniques for linear or exponential amplification of nucleic acid sequences. Illustrative means for performing the amplification step include PCR, nucleic acid strand-based amplification (NASBA), two-step multiplex amplification, rolling circle amplification (RCA), etc., including multiple versions and combinations thereof, such as, but not limited to, OLA / PCR, PCR / OLA, LDR / PCR, PCR / PCR / LDR, PCR / LDR, LCR / PCR, PCR / LCR (also known as combined chain reaction (combined chain reaction - CCR)), helicase-dependent amplification (HDA), etc. Descriptions of these techniques can be found in, among other sources, Ausubel et al.; PCR Primer: A Laboratory Manual, Diffenbach, Ed., Cold Spring Harbor Press (1995); The Electronic Protocol Book, Chang Bioscience (2002); Msuih et al., J. Clin. Micro. 34:501-07 (1996); The Nucleic Acid Protocols Handbook, R. Rapley, ed., Humana Press, Totowa, NJ (2002); Abramson et al., Curr Opin Biotechnol. 1993 Feb.; 4(1):41-7, U.S. Pat. No. 6,027,998; U.S. Pat. No. 6,605,451, Barany et al., PCT Publication No. WO 97 / 31256; Wenz et al., PCT Publication No. WO 01 / 112579; Day et al., Genomics, 29(1):152-162 (1995), Ehrlich et al., Science 252:1643-50 (1991); Innis et al., PCR Protocols: A Guide to Methods and Applications, Academic Press (1990); Favis et al., Nature Biotechnology 18:561-64 (2000); and Rabenau et al., Infection 28:97-102 (2000); Belgrader, Barany and Lubin, Development of a Multiplex Ligation Detection Reaction DNA Typing Assay, Sixth International Symposium on Human Identification, 1995 (available on the Internet at promega.com / geneticidproc / ussymp6proc / blegrad.html-); LCR Kit User Manual, Cat. #200520, Rev. #050002, Stratagene, 2002; Barany, Proc. Natl. Acad. Sci. USA 88:188-93 (1991); Bi and Sambrook, Nucl. Acids Res. 25:2924-2951 (1997); Zirvi et al., Nucl. Acid Res. 27:e40i-viii (1999); Dean et al., Proc Natl Acad Sci USA 99:5261-66 (2002); Barany and Gelfand, Gene 109:1-11 (1991); Walker et al., Nucl. Acid Res. 20:1691-96 (1992); Polstra et al., BMC Inf. Dis. 2:18- (2002); Lage et al., Genome Res. 2003 Feb.; 13(2):294-307, and Landegren et al., Science 241:1077-80 (1988), Demidov, V., Expert Rev Mol Diagn. 2002 Nov.;2(6):542-8., Cook et al., J Microbiol Methods. 2003 May;53(2):165-74, Schweitzer et al., Curr Opin Biotechnol. 2001 Feb.;12(1):21-7, U.S. Pat. No. 5,830,711, U.S. Pat. No. 6,027,889, U.S. Pat. No. 5,686,243, PCT Publication No. WO0056927A3 and PCT Publication No. WO9803673A1. .

[0067] A "multiplex amplification reaction" refers to a reaction in which two or more nucleic acids that are distinguishable by sequence are simultaneously amplified.

[0068] The term "qPCR" herein refers to quantitative real-time polymerase chain reaction (PCR), also known as "real-time PCR" or "kinetic polymerase chain reaction"; all terms refer to PCR with real-time signal detection.

[0069] The term "reagent" refers broadly to any reagent used in a reaction, excluding the analyte (e.g., the nucleic acid being analyzed). Illustrative reagents for nucleic acid amplification reactions include, but are not limited to, buffers, metal ions, polymerases, reverse transcriptases, primers, template nucleic acids, nucleotides, labels, dyes, nucleases, dNTPs, etc. Reagents for enzyme reactions include, for example, substrates, cofactors, buffers, metal ions, inhibitors, and activators.

[0070] As used herein, the term "label" refers to any atom or molecule that can be used to provide a detectable and / or quantifiable signal. In particular, the label can be attached directly or indirectly to a nucleic acid or protein. Suitable labels that can be attached to the probe include, but are not limited to, radioisotopes, fluorophores, chromophores, mass markers, electron-dense particles, magnetic particles, spin labels, chemiluminescent molecules, electrochemically active molecules, enzymes, cofactors, and enzyme substrates.

[0071] The term "dye", as used herein, generally refers to any organic or inorganic molecule that absorbs electromagnetic radiation.

[0072] The naturally occurring bases adenine, thymine, uracil, guanine, and cytosine that make up DNA and RNA are described herein as "unmodified bases" or "unmodified forms."

[0073] The term "modified base", as used herein, refers to a base that is not a canonical naturally occurring base (e.g., adenine, cytosine, guanine, thymine, or uracil). Examples of modified bases are 2-thiothymine and 2-aminoadenine.

[0074] Nucleotides comprising modified bases are referred to herein as "modified nucleotides."

[0075] As used herein, "Tm of a primer" refers to the Tm (melting temperature) of the double-stranded form of the primer.

[0076] "High Tm primer" herein is defined relative to "low Tm primer" in a nucleic acid primer set. The characteristic of "high Tm primer" is that its Tm is higher than the Tm of the low Tm primer.

[0077] The term "pulse" is used herein in reference to a nucleic acid amplification reaction to refer to a step in which the reaction temperature (usually the denaturation temperature in a temperature cycle) is: (1) reduced to an annealing and extension temperature that allows the high Tm primer to anneal and be extended, and then (2) increased to the denaturation temperature. Those skilled in the art will readily appreciate that denaturation can occur over a range of temperatures, and that returning to "the" denaturation temperature need not necessarily return to the exact same denaturation temperature of the reaction before the pulse began. The term "pulse" includes "rapid ramping" of temperature, in which the temperature is reduced to the annealing and extension temperature of the high Tm primer and then immediately increased, as well as situations in which the temperature is reduced to the annealing and extension temperature and maintained for a period of time (usually short).

[0078] Unless otherwise stated, all ranges described herein are inclusive of their endpoints.

[0079] The symbol "^X" refers to the base of nucleic acid exponential amplification. Classical PCR is base 2, so it is expressed as "PCR^2". PCR^3 refers to base 3 PCR, PCR^4 refers to base 4 PCR, and so on.

[0080] Use high Tm and low Tm primer sets to improve amplification efficiency

[0081] The methods described herein utilize nucleic acid primer sets comprising one or more pairs of high Tm and low Tm primers for each target nucleic acid to be amplified. This method is distinct from the method of classical PCR, for example, in classical PCR, primers are designed to have Tm as close as possible. Figure 1 A typical schematic of classical PCR using a probe is shown, where the Tm of the two primers differ by a few degrees, as indicated by the two close arrows on the vertical temperature scale at slightly above 65° C. The Tm of the probe is slightly higher than both primers, at approximately 70° C.

[0082] In contrast, the methods described herein utilize primer pairs with significantly different Tms, such as Figure 2 In this illustrative embodiment, the Tm of the high Tm primer is approximately 82°C, while the Tm of the low Tm primer is slightly above 65°C. Figure 1The classical PCR shown is different, in this example, the Tm of the probe is between the Tm of the high Tm primer and the Tm of the low Tm primer. In various embodiments, the Tm of the probe is at least about 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 degrees Celsius or more higher than the Tm of the low Tm primer. In certain embodiments, the Tm difference can fall within the Tm range defined by any of these values ​​(including endpoints). For example, the Tm difference can be at least 1-10, 2-9, 3-8, 4-7 or 5-6, etc.

[0083] In some embodiments, the Tm difference between the high Tm primer and the low Tm primer can be about: 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30 degrees Celsius or more. In some embodiments, the Tm difference can fall within the Tm range defined by any of these values ​​(including the endpoints). For example, the Tm difference can be about 6-28, 7-25, 8-22, 9-21 or 10-20, etc.

[0084] Classical PCR uses a "forward" primer, which initiates polymerization of the "sense" or "above" or 5' to 3' (reading from left to right) nucleic acid strand. In classical PCR, a "reverse" primer initiates polymerization of the "antisense" or "below" or 3' to 5' (reading from left to right) nucleic acid strand. In some embodiments, the high Tm and low Tm primer pairs described herein are "forward" and "reverse" primer pairs. For example, the high Tm primer can be a forward primer and the low Tm primer can be a reverse primer; or the low Tm primer can be a forward primer and the high Tm primer can be a reverse primer.

[0085] Figure 3 A schematic diagram showing the temperature / time course of a single cycle of one embodiment of the method described herein, wherein the high Tm primer is the forward primer and the low Tm primer is the reverse primer. The novel features of the method are Figure 3 In fact, this temperature pulse and temperature / time course are characteristic of the present method, whether the high Tm primer is a forward primer or a reverse primer.

[0086] like Figure 3 As shown, the pulse helps to synthesize a third nucleic acid strand from the initial double-stranded nucleic acid duplex. If the high Tm primer is a forward primer, then the third nucleic acid strand is the sense strand, such as Figure 3 If the high Tm primer is the reverse primer, then the third nucleic acid strand is the antisense strand.

[0087] In either case, the pulse ends with a return to the denaturation temperature and three nucleic acid chains, which can each serve as a template, and when the temperature is reduced to a temperature suitable for the low Tm primer, the low Tm primer binds to the available template and generates a new nucleic acid chain. At this temperature, the high Tm primer also binds to the available template to generate a new nucleic acid chain. Therefore, a single amplification cycle ends with 3 copies of the initial single nucleic acid duplex, thereby achieving a base 3 PCR ("PCR^3").

[0088] like Figure 3 As shown, if the high Tm primer is the forward primer, during the annealing / extension period suitable for the low Tm primer, the latter (i.e., the reverse primer) will anneal to the two sense strands generated during the pulse to produce two double-stranded duplexes, while the high Tm primer will anneal to the antisense strand to produce another double-stranded duplex.

[0089] If the high Tm primer is the reverse primer, the pulse will generate two antisense strands. During the annealing / extension period for the appropriate low Tm primer, the latter (i.e., the forward primer) will anneal to the two antisense strands, generating two double-stranded duplexes, while the high Tm primer will anneal to the sense strand, generating another double-stranded duplex.

[0090] Inserting a single pulse during the denaturation phase of nucleic acid amplification can increase the number of copies present after one amplification cycle by 1, thereby increasing the base of exponential amplification by 1. Classical PCR is characterized by an exponential increase in the base of amplicon copies of 2. In one embodiment of the method, inserting a single pulse during the denaturation phase of amplification increases the number of copies present after one amplification cycle to 3, thereby achieving an exponential increase with a base greater than 2, theoretically reaching at least base 3. In some embodiments, the method is performed by 2, 3, or 4 additional pulses, which may increase the base of exponential amplification to base 4, base 5, or base 6, respectively. If desired, more pulses can be performed, although each pulse will increase the time of the denaturation phase of amplification, and in many embodiments, in order to avoid unduly extending the time of a single amplification cycle, it is advantageous to limit the number of pulses to a number of pulses that provide the desired results within an appropriate time range (e.g., an appropriate time range for the target assay).

[0091] In some embodiments, the pulse causes a temperature drop of about: 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 degrees Celsius or more, and / or the drop in temperature falls within any range bounded by any of these values ​​(including endpoints). For example, the drop in temperature may be within the range of 6-24, 8-22, 10-20, 12-18, or 14-16 degrees Celsius.

[0092] The temperature drops to the duration of the annealing / extension temperature of the high Tm primer and should be sufficient to extend from the high Tm primer to generate a nucleic acid chain corresponding to the target sequence to be amplified. In some embodiments, the duration of this temperature drop is 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7 or 8 seconds or more, and / or the duration falls within any range defined by any of these values ​​(including endpoints). For example, the duration of this temperature drop may be 0.1-6, 0.2-5, 0.3-4, 0.5-3, 0.6-2, 0.7-1, 1-2, 2-7, 3-6, 3-5 or 3-4 seconds.

[0093] sample

[0094] Samples containing nucleic acids can be obtained from biological sources and prepared using conventional methods known in the art. In particular, samples containing nucleic acids useful in the present method can be obtained from any source, including unicellular organisms and higher organisms, such as plants or non-human animals, such as canines, felines, equines, primates and other non-human mammals, and humans. In certain embodiments, samples can be obtained from individuals suspected of being infected or known to be infected with pathogens (e.g., viruses, bacteria, fungi or parasites), individuals suspected of having or known to have a disease (such as cancer), or pregnant individuals.

[0095] Nucleic acids can be obtained from cells, body fluids (e.g., blood, blood components, urine, etc.), or tissue samples by various standard techniques. In certain embodiments, the samples used in the method include plasma, serum, cerebrospinal fluid, lymph fluid, peritoneal fluid, pleural fluid, oral fluid, and external sections of the skin; samples from the respiratory tract, intestinal tract, reproductive tract, or urinary tract; tears, saliva, blood cells, stem cells, or tumor samples. Samples can be obtained from living or dead organisms, or from in vitro cultures. Example samples can include single cells, paraffin-embedded tissue samples, and puncture biopsies. In certain embodiments, the nucleic acids analyzed are obtained from single cells.

[0096] The nucleic acid of interest can be isolated using methods known in the art.The sample nucleic acid need not be in pure form, but is generally sufficiently pure to allow the steps of the methods described herein to be performed.

[0097] Target nucleic acid

[0098] Any target nucleic acid that can be detected by nucleic acid amplification can be detected using the methods described herein. In typical embodiments, at least some nucleotide sequence information of the target nucleic acid is known. For example, if the amplification reaction used is PCR, there is usually enough sequence information available for each end of a given target nucleic acid to design suitable amplification primers.

[0099] The targets may include, for example, nucleic acids associated with pathogens such as viruses, bacteria, protozoa, or fungi; RNA, such as those whose overexpression or underexpression indicates disease, RNA expressed in a tissue- or development-specific manner; or RNA induced by a specific stimulus; genomic DNA that can be analyzed for specific polymorphisms (such as SNPs), alleles, or haplotypes (e.g., in genotyping). Of particular interest are genomic DNA that is altered (e.g., amplified, deleted, and / or mutated) in genetic diseases or other pathologies; sequences associated with desirable or undesirable traits; and / or sequences that uniquely identify an individual (e.g., in forensics or paternity testing).

[0100] Primer design

[0101] Primers suitable for nucleic acid amplification are long enough to initiate the synthesis of extension products in the presence of a suitable nucleic acid polymerase. The exact length and composition of the primers depend on many factors, including, for example, the temperature of the annealing reaction, the source and composition of the primers, and in the case of using probes, the proximity of the probe annealing site to the primer annealing site, and the ratio of primer:probe concentration. For example, depending on the complexity of the target nucleic acid sequence, an oligonucleotide primer typically contains about 10 to about 60 nucleotides, although it may contain more or less nucleotides. The primers should be sufficiently complementary to selectively anneal with each chain and form a stable duplex.

[0102] In general, those skilled in the art know how to design suitable primers that can amplify a target nucleic acid of interest. For example, PCR primers can be designed using any commercially available software or open source software, such as Primer3 (see, e.g., Rozen and Skaletsky (2000) Meth. Mol. Biol., 132: 365-386; www.broad.mit.edu / node / 1060, etc.) or by accessing the Roche UPL website. The amplicon sequence is input into the Primer3 program, and the UPL probe sequence is included in brackets to ensure that the Primer3 program will design primers on either side of the probe sequence in the brackets.

[0103] Adjust the Tm of primers or probes

[0104] The Tm (melting temperature) can be adjusted by adjusting the length of the sequence, the GC content, and / or including stabilizing or destabilizing bases in the sequence.

[0105] "Stable bases" include, for example, peptide nucleic acid (PNA) fragments that can be incorporated into DNA oligonucleotides to increase duplex stability. Locked nucleic acids (LNA) and unlocked nucleic acids (UNA) are analogs of RNA that can be easily incorporated into DNA oligonucleotides during solid phase oligonucleotide synthesis to increase and decrease duplex stability, respectively. Suitable stable bases also include modified DNA bases that increase base pair stability (thereby increasing the stability of the entire duplex). These modified bases can be incorporated into oligonucleotides during solid phase synthesis and provide a more predictable method for increasing DNA duplex stability. Examples include AP-dC (G-clamp) and 2,6-diaminoadenine, as well as 5-methylcytosine and C(5)-propynylcytosine (replacing cytosine), and C(5)-propynyluracil (replacing thymine).

[0106] "Destabilizing bases" are bases that destabilize double-stranded DNA by forming base pairs that are less stable than typical AT and / or GC base pairs. Inosine (I) is a destabilizing base because it pairs with cytosine (C), but IC base pairs are less stable than GC base pairs. This lower stability is because inosine is a purine that can only form two hydrogen bonds, compared to GC base pairs that can form three hydrogen bonds. Other destabilizing bases are known or readily identifiable by those skilled in the art.

[0107] Primers can be prepared by any suitable method, including, for example, direct chemical synthesis methods, by phosphotriester methods such as Narang et al. (1979) Meth. Enzymol. 68: 90-99; Brown et al. (1979) Meth. Enzymol. 68: 109-151; Beaucage et al. (1981) Tetra. Lett., 22: 1859-1862 diethylphosphoramidite method; U.S. Pat. No. 4,458,066 solid phase support method, etc., or can be obtained from commercial sources. Primers can be purified using Sephadex columns (Amersham Biosciences, Inc., Piscataway, NJ) or other methods known to those skilled in the art. Primer purification may increase the sensitivity of the methods described herein.

[0108] Polymerase

[0109] Method disclosed herein has used polymerase to amplify.This type of polymerase is well-known, and those skilled in the art easily select suitable polymerase for specific embodiments.In some embodiments, polymerase is a DNA polymerase, which has or lacks 5' to 3' exonuclease activity.In some embodiments, polymerase is a polymerase that is adapted to "hot start".The most widely used polymerase is Taq and Tth polymerase in native form and mutant form.

[0110] Illustrative polymerase concentration ranges are about 20-200 units / reaction. In various embodiments, the polymerase concentration can be at least: 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190 or 200 or more units / reaction. In some embodiments, the polymerase concentration falls within the range defined by any of these values, for example, 10-200, 10-150, 10-100, 10-50, 20-150, 20-100, 20-50, 50-200, 50-150, 50-100, 100-200, 100-150 etc. units / reaction.

[0111] Amplification

[0112] The above primer set is contacted with the sample nucleic acid under conditions where the primer anneals to its template strand (if present). The desired nucleic acid amplification method is performed using a suitable DNA polymerase.

[0113] When amplification is performed using the above dual primer set and a single pulse, approximately 3 循环数 In some embodiments, this base 3 amplification method can reduce the number of amplification cycles required to detect the target nucleic acid by about 12% to about 42%. Examples 1-3 show that in several illustrative embodiments, this method reduces the number of amplification cycles required to detect the target nucleic acid by about 37%.

[0114] When the dual primer set and two pulses are used for amplification, approximately 4 循环数 In some embodiments, this base 4 amplification method can reduce the number of amplification cycles required to detect the target nucleic acid by about 27% to about 57%. Examples 1-3 show that in several illustrative embodiments, this method reduces the number of amplification cycles required to detect the target nucleic acid by about 52%.

[0115] In some embodiments, the amplification step is performed using PCR. When performing a real-time PCR reaction, the reaction mixture typically contains an appropriate buffer, magnesium ions (Mg 2+) in the range of about 1 mM to about 10 mM (e.g., in the range of about 2 mM to about 8 mM), and a concentration of 100 μg / mL. 2 + ) source, nucleotides, and optionally, detergents and stabilizers. An example of a suitable buffer is TRIS buffer, with a concentration of about 5mM to about 85mM, preferably 10mM to 30mM. In one embodiment, the concentration of the Tris buffer in the double concentrated (2X) form of the reaction mixture is 20mM. The pH range of the reaction mixture can be about 7.5 to about 9.0, and a typical pH range is about 8.0 to about 8.5. The concentration of nucleotides can be in the range of about 25mM to about 1000mM, typically in the range of about 100mM to about 800mM. Examples of dNTP concentrations are 100, 200, 300, 400, 500, 600, 700 and 800mM. Detergents such as TWEEN 20, TRITON X 100, BRIJ and NONIDET P40 may also be included in the reaction mixture. Stabilizers such as dithiothreitol (DTT, Cleland's reagent) or mercaptoethanol may also be included. In addition, the premix optionally contains dUTP and uracil DNA glycosylase (uracil-N-glycosylase, UNG). The premix was purchased from Applied Biosystems, Foster City, CA, ( Universal Master Mix, catalog numbers 4304437, 4318157, and 4326708). In some embodiments, the reaction mixture contains one or more amplification enhancers, such as dimethyl sulfoxide (DMSO), bovine serum albumin (BSA), tetramethyl sulfoxide (TMSO), acetamide, betaine, etc. DMSO is a Tm lowering agent and can be used to reduce the Tm of the amplicon by approximately 3-4 degrees; therefore, the time required for the denaturation step can be reduced.

[0116] Tagging strategy

[0117] In the methods described herein, any suitable labeling strategy can be used. If the reaction is to analyze the presence of a single amplification product, a universal detection probe can be used in the amplification mixture. In a specific embodiment, a universal qPCR probe can be used for real-time PCR detection. Suitable universal qPCR probes include double-stranded DNA binding dyes such as SYBRGreen, Pico Green (Molecular Probes, Inc., Eugene, OR), Eva Green (Biotium), ethidium bromide, etc. (see Zhu et al., 1994, Anal. Chem. 66: 1941-48).

[0118] In some embodiments, one or more target-specific qPCR probes (i.e., specific for the target nucleotide sequence to be detected) can be used in the amplification mixture to detect the amplification product. Through judicious selection of labels, analysis can be performed in which different labels are excited and / or detected at different wavelengths in a single reaction ("multiplexed detection"). See, for example, Fluorescence Spectroscopy (Pesce et al., eds.), Marcel Dekker, New York, (1971); White et al., Fluorescence Analysis: A Practical Approach, Marcel Dekker, New York, (1970); Berlman, Handbook of Fluorescence Spectra of Aromatic Molecules, 2nd ed., Academic Press, New York, (1971); Griffiths, Color and Constitution of Organic Molecules, Academic Press, New York, (1976); Indicators (edited by Bishop), Pergamon Press, Oxford, 19723; and Haugland, Handbook of Fluorescent Probes and Research Chemicals, Molecular Probes, Eugene (1992); and Linck et al. (2017) "A multiplex TaqMan qPCR assay for sensitive and rapid detection of phytoplasmas infecting Rubus species,” PLOS One 12(5).

[0119] In some embodiments, it may be convenient to include a label on one or more of the primers used in the amplification mixture.

[0120] Cycle Probe

[0121] In some embodiments, the circulating probe can be used to detect and optionally quantify the target nucleic acid in the methods described herein. Circulating probes have been used as a method for amplifying signals in amplification assays for many years. Circulating probes are described in, for example, PCT Publication No. WO 89 / 09284 and U.S. Patent Nos. 5,011,769 and 4,876,187, and the descriptions of these patent publications and patents to circulating probes are incorporated herein by reference.

[0122] U.S. Patent No. 5,763,181 describes the use of fluorescently labeled circulating probes for detecting target nucleic acids. Generally, the disclosed method uses a fluorescently labeled oligonucleotide substrate containing a nucleotide sequence recognized by an enzyme that catalyzes a cleavage reaction. The oligonucleotide substrate can be DNA or RNA, and can be single-stranded or double-stranded. The oligonucleotide can be labeled with a single fluorescent marker on a single strand of DNA or RNA, or with a pair of fluorescent markers (donor and acceptor). The selection of a single marker or a double marker can depend on the efficiency of the enzyme used in the method of the present invention. There is no limit to the length of the oligonucleotide substrate, as long as the fluorescent probe is labeled far enough away from the enzyme cleavage site (e.g., 6-7 nucleotides). Examples of fluorophores commonly used in this method include: fluorescein isothiocyanate, aminofluorescein, eosin, rhodamine, dansyl and umbelliferone. Other fluorescent markers are well known to those skilled in the art. Heller and Jablonski provide some general guidance on designing sensitive fluorescently labeled polynucleotide probes in U.S. Patent No. 4,996,143. The patent discusses parameters that can be considered when designing fluorescent probes. The cycling probe cleavage reaction can be catalyzed by enzymes such as DNA enzymes, RNA enzymes, helicases, exonucleases, restriction endonucleases, or retroviral integrases. Other enzymes that cleave nucleic acids are well known to those skilled in the art and can be used to cleave cycling probes with homologous cleavage sites.

[0123] In some embodiments, any probe described herein may include one or more modified bases. The above discussion on stable and / or modified bases in probes also applies to probes.

[0124] In some embodiments, it may be convenient to include a label on one or more of the primers used in the amplification mixture.

[0125] Primer / probe concentration

[0126] Primer and probe (if present) can be added in the amplification mixture with the typical concentration for amplification method (such as PCR).In some embodiments, primer is added with relatively high concentration to facilitate rapid annealing / hybridization, to promote rapid pulse and circulation.In some embodiments, the concentration of high Tm and low Tm primer is identical, for example, at least 500,550,600,650,700,750,800 or 850nM (each primer).In some embodiments, the concentration of each primer falls in the range defined by any of these values ​​(including endpoints), for example, 550-850nM, 600-850nM, 650-850nM, 700-850nM or 750-850nM.In the following examples, the concentration of primer is 800nM.

[0127] Exemplary Automation and Systems

[0128] In some embodiments, an automated sample processing and / or analysis platform is used to detect the target nucleic acid. In some embodiments, a commercially available automated analysis platform is utilized. For example, in some embodiments, a System (Cepheid, Sunnyvale, CA).

[0129] The methods described herein illustrate the use of the GeneXpert system. Exemplary sample preparation and analysis methods are described below. However, the present invention is not limited to a specific detection method or analysis platform. Those skilled in the art recognize that any number of platforms and methods may be used.

[0130] An independent, disposable box is used. Sample extraction, amplification and detection can all be completed in this independent "laboratory in a box" (available from Cepheid - see www.cepheid.com). Those skilled in the art will recognize that the methods disclosed herein are applicable to the use of other box-based systems that include boxes with multiple fluid-connected chambers that are located in a single disposable box body, providing automated sample preparation, nucleic acid extraction, amplification and detection. In some embodiments, the box allows storage of dry reagents and provides automated fluid movement, reagent rehydration and mixing during sample processing. In some embodiments, the box includes multiple fluid channels to prevent or limit bubble entrapment and contamination, while allowing thermal cycling and optical monitoring of the reaction process in a reaction chamber extending from the box body.

[0131] The components of the box include but are not limited to processing cells containing reagents, filters and capture techniques, which are very useful for extraction, purification and amplification of target nucleic acids. In some embodiments, a rotary valve can be used to transfer fluid between cells, which may contain nucleic acid cracking and filtering components. Optical windows make real-time optical detection possible. Reaction tubes make very fast thermal cycles possible.

[0132] In some embodiments, The system consists of multiple modules for scalability. Each module is configured with fluid sample handling and analysis components.

[0133] After the sample is added to the box, the sample is contacted with a lysis buffer, and the released nucleic acid is bound to a nucleic acid binding substrate (e.g., a silica or glass substrate). The sample supernatant is then removed and the nucleic acid is eluted in an elution buffer (e.g., a Tris / EDTA buffer). The eluent can then be processed in the box to detect the target gene described herein. In some embodiments, the eluent is used to reconstitute at least a portion of the reagents present in the box in the form of lyophilized particles.

[0134] In some embodiments, PCR is used to amplify and detect the presence of one or more target nucleic acids. In some embodiments, PCR uses a Taq polymerase with a hot start function, such as AptaTaq (Roche).

[0135] In some embodiments, off-line centrifugation is used to improve assay results for samples with low cell content. The sample (with or without buffer) is centrifuged and the supernatant is removed. The pellet is then resuspended in a smaller volume of supernatant, buffer, or other liquid. The resuspended pellet is then added to In the box, as described above.

[0136] In some embodiments, a continuous convection device can be used to perform the methods described herein. The device achieves thermal cycling by moving the reaction mixture to different temperature zones. Convection PCR and suitable devices for classical PCR are described in Wheeler et al. (2004) "Convectively Driven Polymerase Chain Reaction Thermal Cycler," 76: 4011-4016. Fig. 8A A schematic diagram of such an apparatus is shown, and Figure 8B It is shown how such a device can be designed for use in the methods described herein.

[0137] Reagent test kit

[0138] Kits for performing the methods described herein are also contemplated. Such kits contain one or more reagents useful for implementing any of these methods. Kits typically include packaging containing one or more containers for holding reagents, wherein the reagents are provided as one or more separate compositions, or optionally as a mixture (if reagent compatibility permits). The kit may also include other materials that may be desired from a user's perspective, such as buffers, diluents, standards, and / or any other materials useful for sample processing, washing, or performing any other assay steps.

[0139] The kit preferably includes instructions for performing one or more screening methods described herein. The instructions contained in the kit can be attached to the packaging material, or can be included as a package insert. Although the instructions are generally written or printed materials, they are not limited to this. Any medium that can store such instructions and communicate them to the end user can be used. These media include, but are not limited to, electronic storage media (e.g., disks, tapes, cassettes, chips), optical media (e.g., CD ROM), etc. As used herein, the term "instructions" may include an Internet website address that provides the instructions.

[0140] Example

[0141] Example 1: Comparison of real-time amplification curves of hgDNA β-globin housekeeping gene sequences generated by PCR^2 and PCR^3 using TaqMan probes

[0142] In this example, to increase the rate of the hybridization reaction, the oligonucleotide concentration was 800 mM each. Table 1 lists the sequences of the forward and reverse primers and probes (containing modified nucleotides C* and A* that stabilize Tm), Table 2 shows the components of the PCR premix, and Table 3 shows the temperature / time course.

[0143] Table 1

[0144]

[0145] The modified nucleotides that stabilize Tm are designated as C* and A*, which refer to 5-methylcytosine and 2,6-diaminoadenine, respectively. T* refers to the modified thymine that stabilizes Tm. FAM and BHQ1 stand for Fluorescein amidite and Black Hole quencher, respectively.

[0146] Table 2

[0147]

[0148]

[0149] Table 3

[0150] PCR method (^X) Temperature-time mode (temperature unit is ℃ / time unit is second) PCR^2 95 / 6–63 / 8 PCR^3 95 / 4–80 / 4–95 / 4–63 / 8

[0151] The PCR instrument used was PCRMAX ECO 48.

[0152] The results are as follows Figure 5 As shown. Compared with PCR^2, the Ct value of PCR^3 decreased by 10 cycles. In addition, at the beginning of the exponential amplification phase, each new cycle of the PCR^3 curve increased the FAM signal by a factor of 3 relative to the previous cycle. In the case of PCR^2, the factor was only 2.

[0153] The endpoint fluorescence (EPF) generated by PCR^3 is approximately twice that of PCR^2. Although not being bound by any particular theory, this phenomenon may be related to the reduced competition between the formation of the double-stranded amplicon complex and the hybridization of the primers and probes to the single-stranded amplicon. The high Tm primers can effectively compete with the formation of the double-stranded amplicon complex, which allows the low Tm primers and probes to hybridize to the complementary amplicon strands. Therefore, the reaction can produce a higher FAM signal.

[0154] Example 2: Comparison of PCR^2 with PCR^3 and PCR^4

[0155] In this example, the same oligonucleotides and reaction mixtures as in Example 1 were used (see Tables 1 and 2), and the results of temperature / time courses using one (PCR^3) or two (PCR^4) pulses were compared. Table 4 shows the temperature / time course for each PCR base.

[0156] Table 4

[0157] PCR method (^X) Temperature-time mode (temperature unit is ℃ / time unit is second) PCR^2 96 / 3–62 / 4 PCR^3 96 / 3–80 / 3–96 / 3–63 / 4 PCR^4 96 / 3–80 / 3–96 / 3–80 / 3–96 / 3–63 / 4

[0158] The PCR instrument used was a Cepheid GX with an in-house programming language, GXterm.

[0159] The results are as follows Figure 6 As shown in Figure 3, the Ct value of PCR^4 decreased by 4 cycles compared with PCR^3 and decreased by 14 cycles compared with PCR^2.

[0160] Example 3: Comparison of real-time amplification curves of alternative hgDNA β-globin housekeeping gene sequences generated by PCR^2 and PCR^3 using TaqMan probes

[0161] PCR^2 and PCR^3 were performed essentially as described above for alternative hgDNA β-globin housekeeping gene sequences using the primer and probe designs shown in Table 5 (including modified nucleotides C* and A* that stabilize Tm). The concentration of the oligonucleotides was 800 mM each to increase the rate of the hybridization reaction. The PCR master mix components were as shown in Table 2, but with the addition of 5% DMSO.

[0162] Table 5

[0163]

[0164] The modified nucleotides that stabilize Tm are designated as C* and A*, referring to 5-methylcytosine and 2,6-diaminoadenine, respectively. FAM and BHQ1 represent fluorescein phosphoramidite and black hole quencher, respectively.

[0165] The results are as follows Figure 7 As shown, as in Example 1, for the alternative hgDNA β-globin housekeeping gene sequence target, the Ct value of PCR^3 was reduced by 10 cycles relative to PCR^2.

Claims

1. A method for amplifying a target nucleic acid in a sample to produce a target amplicon, the method comprising using a nucleic acid primer set comprising a high Tm primer and a low Tm primer, wherein: The target nucleic acid comprises a first template strand and optionally a second template strand, wherein the second template strand is complementary to the first template strand; The high Tm primer is capable of annealing to the first template strand and priming an extension product from the high Tm primer; The low Tm primer is capable of annealing to the first extension product and priming the extension product from the low Tm primer; wherein the Tm of the high Tm primer is at least 5°C higher than the Tm of the low Tm primer. 2 . The method of claim 1 , wherein the Tm of the high Tm primer is at least 10° C. higher than the Tm of the low Tm primer.

3. The method of claim 1, wherein the Tm of the high Tm primer is at least 15°C higher than the Tm of the low Tm primer. The method of claim 1 , wherein the Tm of the high Tm primer is at least 20° C. higher than the Tm of the low Tm primer. The method of claim 1 , wherein the Tm of the high Tm primer is at least 25° C. higher than the Tm of the low Tm primer.

6. A method according to any preceding claim, wherein the method comprises: contacting the sample with a reaction mixture comprising the nucleic acid primer set; Raising the reaction temperature to a denaturation temperature, thereby denaturing the nucleic acid in the sample; Pulsing the reaction by lowering the reaction temperature to a high annealing and extension temperature suitable for producing extension products from the high Tm primer and then raising the reaction temperature to the denaturation temperature; reducing the reaction temperature to a low annealing and extension temperature suitable for producing an extension product from the low Tm primer, wherein the high Tm primer also anneals and produces another extension product; The pulse is capable of generating additional amplicons beyond the number of amplicons generated by a single amplification cycle on a double-stranded template in the absence of the pulse.

7. The method of claim 6, wherein the pulse is performed at least once in each amplification cycle.

8. The method of claim 6, wherein the pulse is performed at least twice in each amplification cycle.

9. The method of claim 6, wherein the pulse is performed at least three times in each amplification cycle.

10. The method of claim 6, wherein the pulse is performed at least four times in each amplification cycle.

11. The method according to any one of claims 6 to 10, wherein: The denaturation temperature includes a temperature of 90°C to 100°C; The high annealing and extension temperatures include temperatures from 75°C to 85°C; and The low annealing and extension temperatures include temperatures from 60°C to 70°C.

12. The method of claim 11, wherein the method comprises performing a plurality of amplification cycles, wherein each amplification cycle comprises subjecting the reaction mixture sequentially to the following temperatures: Denaturation temperature of 92°C to 98°C; High annealing and extension temperatures from 75°C to 83°C; a denaturation temperature of 92°C to 98°C; and Low annealing and extension temperatures of 60°C to 66°C.

13. The method of any one of claims 6 to 12, wherein the reaction mixture is maintained at the denaturation temperature and the high annealing and extension temperature for the same amount of time, and is maintained at the low annealing and extension temperature for an amount of time longer than that amount of time.

14. The method of claim 13, wherein each amplification cycle comprises, in the following order: Denature at 94-96°C for 3-6 seconds; high annealing and extension at 79-81°C for 0.1-6 seconds; Denature at 94-96°C for 3-6 seconds; as well as Low annealing and extension at 63-64 °C for 3-8 sec.

15. The method of claim 11, wherein the pulse is performed at least twice in each amplification cycle, and the method comprises performing a plurality of amplification cycles, wherein each amplification cycle comprises subjecting the reaction mixture sequentially to the following temperatures: Denaturation temperature of 92°C to 98°C; High annealing and extension temperatures from 75°C to 83°C; Denaturation temperature of 92°C to 98°C; High annealing and extension temperatures from 75°C to 83°C; Denaturation temperature of 92°C to 98°C; Low annealing and extension temperatures including temperatures of 60°C to 66°C.

16. The method of claim 15, wherein the reaction mixture is maintained at the denaturation temperature and the high annealing and extension temperature for the same amount of time and at the low annealing and extension temperature for twice that amount of time.

17. The method of claim 15, wherein each amplification cycle comprises, in the following order: Denature at 94-96°C for 3-6 seconds; high annealing and extension at 79-81°C for 0.1-6 seconds; Denature at 94-96°C for 3-6 seconds; high annealing and extension at 79-81°C for 0.1-6 seconds; Denature at 94-96°C for 3-6 seconds; as well as Low annealing and extension at 63-64 °C for 3-8 seconds.

18. The method according to any preceding claim, wherein the method further comprises detecting the target amplicon using a detection probe.

19. The method according to any of the preceding claims, wherein the nucleic acid amplification is a multiplex amplification using at least two nucleic acid primer sets for amplifying at least two target nucleic acids, each nucleic acid primer set comprising a high Tm primer and a low Tm primer, wherein: For each nucleic acid primer set, the Tm of the high Tm primer is at least 5°C higher than the Tm of the low Tm primer.

20. A nucleic acid primer set comprising the primer according to any one of claims 1 to 4 or 19.